#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anaplastic large cell lymphoma T- and null-cell types Huntington's disease Encephalitis autoimmune Glomerulonephritis chronic Mantle cell lymphoma stage III Cutaneous calcification Desmoplastic small round cell tumour Ataxia telangiectasia Anal cancer Myeloproliferative neoplasm Liver abscess Krabbe's disease Ocular myasthenia High-grade B-cell lymphoma Bladder cancer More trials…

    Learn about Rare Diseases

    Chondrosarcoma Encephalitis autoimmune – Basic Information Familial haemophagocytic lymphohistiocytosis – Treatment Cystic fibrosis – Basic Information Rhabdoid tumour – Life with Disease Wolfram syndrome – Basic Information Cerebral arteriovenous malformation haemorrhagic – Basic Information Immunodeficiency congenital – Basic Information Paraneoplastic neurological syndrome – Basic Information Breast angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Art6043 Eptacog Beta (Activated) Sulodexide Pegcetacoplan Ulotaront Thalidomide Fenofibrate Dexrazoxane Inotuzumab Ozogamicin Tumor Necrosis Factor-Alpha Sertraline Chlorambucil Pyruvic Acid Fosinopril Sodium Oxybutynin Pralatrexate Doxylamine Hydrogen Succinate TRIACYLGLYCEROL LIPASE Eo2317 Human Mesenchymal Stem Cells More therapies…

    Learn about Your Condition

    Bacterial prostatitis Colon cancer stage IV Dry mouth Myxofibrosarcoma Intestinal obstruction Labour induction Retinoblastoma Bone metabolism disorder Rectal cancer stage II Periodontitis Primary hyperoxaluria Intracranial aneurysm Post procedural complication Urinary incontinence Craniotomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Graalum

  • Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    Austria Belgium Bulgaria Czechia Finland France +10

  • A study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    Bulgaria Greece Hungary Norway Romania Spain

  • Study of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma metastatic
    Investigated Drugs:
    • Pegfilgrastim
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Germany Ireland +5

  • A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Salbutamol Sulfate
    • Depemokimab
    Belgium Croatia Denmark France Germany Hungary +8

  • A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness

    Recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Bulgaria Croatia Czechia France Germany Greece +6

  • A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

    Recruiting

    3 1
    Bulgaria Croatia Czechia France Germany Greece +6
1 2 3 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Tenecteplase Apixaban Hydrocortisone Clopidogrel Prednisone Alteplase Nivolumab Acetylsalicylic Acid Asundexian Dexamethasone Pembrolizumab Cisplatin Placebo Enzalutamide Cloxacillin Doxorubicin Hydrochloride Lenalidomide Entecavir Gemcitabine Hydrochloride Dalteparin Sodium Nitrous Oxide Piperacillin Sodium Polatuzumab Vedotin Cortisone Ianalumab Povetacicept Oxygen Prednisolone Tazobactam Sodium Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute myocardial infarction Alcohol use disorder Amyotrophic lateral sclerosis Aortic valve stenosis Arteriosclerosis Atrial fibrillation Bladder cancer Cancer pain Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic obstructive pulmonary disease Cold type haemolytic anaemia Deafness neurosensory Depression Diffuse large B-cell lymphoma refractory Glioblastoma Hormone-refractory prostate cancer Hypertension IgA nephropathy Immune thrombocytopenia Iron deficiency Ischaemic stroke Labour induction Low anterior resection syndrome Lung disorder Major depression Malignant melanoma Metabolic dysfunction-associated steatohepatitis Metastatic neoplasm Migraine Monkeypox Non-alcoholic steatohepatitis Non-small cell lung cancer Non-small cell lung cancer metastatic Pancreatic carcinoma Plasma cell myeloma Pneumonia Primary adrenal insufficiency Pulmonary embolism Renal cell carcinoma Retinal artery occlusion Sepsis Substance use disorder Thrombosis prophylaxis Transient ischaemic attack Transitional cell carcinoma metastatic Type 2 diabetes mellitus Type IIa hyperlipidaemia Warm autoimmune haemolytic anaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!